Treatment options for patients with epithelioid hemangioendothelioma vary dependent on disease status, but more therapies are ...

Betty Ting Pei, the actress at the center of Bruce Lee’s sudden death in 1973, gave a rare and emotional interview for Part 3 ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

California-based biopharmaceutical company Amgen (NASDAQ:AMGN) is set to announce its second quarter earnings result on ...

New research suggests adults who completed childhood DTaP vaccines may not need tetanus boosters every 10 years, although ...

GAAP earnings per share of $1.29 surpassed estimates of $1.18 in Q2 2025, This figure represents a 143.4% increase compared to Q2 2024. GAAP revenue reached $96.0 million, up 36.6% compared to Q2 2024 ...

Physicians are raising the alarm over the brain-eating amoeba Naegleria fowleri after a 12-year-old boy died from the ...

A Senate committee has rejected President Donald Trump’s efforts to gouge funding for the National Institutes of Health (NIH) ...

Alex Able, 30, was just 29 when he was diagnosed with an extremely rare form of cancer that affects only a handful of people ...

The accountant began suffering from severe headaches during her 20s until she was diagnosed with brain arteriovenous ...

Precision BioSciences Inc., a clinical-stage company developing gene editing therapies for diseases with high unmet need, has ...

Pegcetacoplan inhibits C3 activation by binding to C3 and its activation fragment C3b, thereby reducing C3 glomerular fragment deposition in patients with C3G and primary IC-MPGN.